RCT Comparing Non-operative vs Operative Treatment of Suprasyndesmotic Ankle Fractures.
Non-operative Versus Operative Treatment of Suprasyndesmotic Ankle Fractures: A Prospective, Multicentre, Randomised Controlled Trial
1 other identifier
interventional
120
1 country
4
Brief Summary
Weight-bearing radiographs will be used to evaluate the stability of suprasyndesmotic ankle fractures. Patients with stable fractures will be randomised to operative or non-operative treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2020
CompletedFirst Posted
Study publicly available on registry
November 4, 2020
CompletedStudy Start
First participant enrolled
December 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMay 16, 2025
May 1, 2025
4.4 years
October 28, 2020
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Olerud-Molander Ankle Score (OMAS)
The primary outcome measure is the Olerud-Molander Ankle Score (OMAS), which is a condition-specific, patient-reported measure of ankle-fracture symptoms. OMAS ranges from 0 to 100, with higher scores indicating better outcomes and fewer symptoms.
The main statistical analysis of the primary outcome will be based on the two-year follow-up.
Secondary Outcomes (6)
Ankle pain
The main statistical analysis of the outcome will be based on the two-year follow-up.
Manchester-Oxford Foot Questionnaire (MOxFQ)
The main statistical analysis of the outcome will be based on the two-year follow-up.
EuroQol questionnaire (EQ-5D)
The main statistical analysis of the outcome will be based on the two-year follow-up.
Radiographic results
The main statistical analysis of the outcome will be based on the two-year follow-up.
Range of motion
The main statistical analysis of the outcome will be based on the two-year follow-up.
- +1 more secondary outcomes
Study Arms (2)
Surgical treatment
ACTIVE COMPARATORPatients randomised to operative treatment will have their surgery performed by an orthopaedic surgeon or by orthopaedic trainees under the supervision of a consultant, when fit for surgery. The surgical technique and choice of implants will be decided by the surgeon in order to closely resemble everyday clinical practice. The syndesmosis must be reduced (closed or open) and fixed. Postoperatively, the patients will be treated with an ankle orthosis for six weeks with weight-bearing as tolerated.
Non-surgical treatment
EXPERIMENTALPatients randomised to non-operative treatment are treated with an ankle orthosis for six weeks with weight-bearing as tolerated. Other types of casts can be used if preferred by the treating orthopaedic surgeon, but the cast must allow full weight-bearing and must prevent equinus position.
Interventions
Non-surgical treatment of suprasyndesmotic ankle fractures
Eligibility Criteria
You may qualify if:
- patients who present with a closed, isolated fibular fracture classified as suprasyndesmotic (Weber C) with a medial clear space of less than 7 mm in mortise view on primary radiographs.
- presentation less than 14 days after the injury.
You may not qualify if:
- previous fractures or ligamentous injury to the injured ankle.
- pathological fracture.
- diabetic neuropathy or other neuropathies.
- drug abuse.
- inability to consent and/or comply.
- inability to understand Norwegian language.
- inability to walk unaided prior to the fracture.
- patients with a concomitant tibial fracture requiring surgical treatment are excluded, but patients with undisplaced concomitant tibial fractures can be included.
- patients from outside the catchment area of the recruiting hospitals. However, they can be included if they are willing to undergo follow-up visits at one of the recruiting hospitals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sykehuset Innlandet HFlead
- Oslo University Hospitalcollaborator
- Vestre Viken Hospital Trustcollaborator
- Ostfold Hospital Trustcollaborator
Study Sites (4)
Vestre Viken Hospital Trust
Bærums verk, Akershus, 1347, Norway
Østfold Hospital Trust
Fredrikstad, Akershus, 1714, Norway
Sykehuset Innlandet HF
Gjøvik, Innlandet, 2819, Norway
Oslo University Hospital
Oslo, Oslo County, 4950, Norway
Related Publications (1)
Saatvedt O, Riiser M, Frihagen F, Figved W, Madsen JE, Molund M, Furunes H. Non-operative versus operative treatment of suprasyndesmotic ankle fractures: protocol for a prospective, multicentre, randomised controlled trial. BMJ Open. 2024 Jan 8;14(1):e075122. doi: 10.1136/bmjopen-2023-075122.
PMID: 38191245DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Håvard Furunes, PhD
Sykehuset Innlandet HF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data will be plotted into a database by an independent blinded data manager.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 28, 2020
First Posted
November 4, 2020
Study Start
December 28, 2020
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
We have planned to use all the IPD only within the present study group.